In a report released on November 11, Mike Kratky from Leerink Partners reiterated a Hold rating on Inspire Medical Systems (INSP – Research Report), with a price target of $197.00. Mike Kratky’s ...
The Horizon® 3.0 Inspire has a compact design allowing for easier portability ... The Horizon 3.0 Transcranial Magnetic Stimulation (TMS) Therapy System is a computerized, noninvasive medical device ...
Inspire Medical Systems (NYSE:INSP) announced today that it entered into an accelerated share repurchase program worth $75 ...
Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for ...